Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

For some, that extended to alcohol, too. Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical study results that support ...

A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than those taking DPP-4 drugs.

1.36 ±0.05-fold [scrambled siRNA] expansion in 48 h; P < 0.05)(Fig. 5). Cyclin A2 knockdown completely inhibited exendin-4-induced proliferation stimulation in Min6 cells (Fig. 5). Lentiviral ...

GLP-1 therapies have demonstrated significant cardiometabolic benefits, particularly in high-risk patients with cardiovascular disease. Recent trials have shown the effectiveness of GLP-1 ...

BIRMINGHAM, Ala. (WBRC) - Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become popular when used as a weight loss drug. But, ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced ... ever conducted on the drug class – based on 2.4 million people in the US Department of Veterans ...